RedHill Biopharma Ltd.
RDHL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001553846
In the last 90 days, RedHill Biopharma Ltd. insiders filed 0 open-market purchases and 1 sale; 14 institutions reported holding it in 13F filings for Q2 2026, worth $270.0K in total; no superinvestor holds it.
Holders of 5% or more of RDHL
Holders whose latest Schedule 13D or 13G filing reports 5% or more of RedHill Biopharma Ltd., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Alumni Capital LP | 13G | 9.99%369.4K shares | New | Oct 20, 20251 filing | Oct 20, 2025 | SEC |
| YA II PN, Ltd. | 13G | 9.90%508.7K shares | New | Dec 23, 20251 filing | Dec 23, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
13 Schedule 13D and 13G filings on RedHill Biopharma Ltd., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Dec 23, 20254:05 PM ET | YA II PN, Ltd.and 7 others | 13G | 9.90%508.7K shares | New | Dec 19, 2025 | SEC |
| Oct 20, 20256:48 PM ET | Alumni Capital LPand 2 others | 13G | 9.99%369.4K shares | New | Jun 20, 2025 | SEC |
| Nov 14, 2024 | CVI Investments, Inc. | 13G/AOld format | – | – | – | SEC |
| Aug 7, 20244:43 PM ET | Quintairos, Prieto, Wood & Boyer P.A. | 13D | 0.00%0 shares | NewBelow 5% | Mar 22, 2024 | SEC |
| Feb 2, 2024 | Intracoastal Capital, LLC | 13GOld format | – | New | – | SEC |
| Feb 1, 2024 | CVI Investments, Inc. | 13GOld format | – | New | – | SEC |
| Jan 8, 2024 | Empery Asset Management, LP | 13G/AOld format | – | – | – | SEC |
| Jan 2, 2024 | Sabby Management, LLC | 13G/AOld format | – | – | – | SEC |
| Jan 13, 2023 | Empery Asset Management, LP | 13GOld format | – | New | – | SEC |
| Jan 4, 2023 | Sabby Management, LLC | 13GOld format | – | New | – | SEC |
| Mar 7, 2022 | Cosmo Pharmaceuticals N.V. | 13GOld format | – | New | – | SEC |
| Jan 27, 2022 | Ibex Investors LLC | 13G/AOld format | – | – | – | SEC |
| Jan 15, 2021 | Ibex Investors LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell RedHill Biopharma Ltd. shares.
No Form 144 notices for RedHill Biopharma Ltd. are on file.